Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
20.57(c) 20.77(c) 20.68(c) 20.94(c) 20.72 Last
1 911 556 1 229 429 1 145 496 1 156 828 737 845 Volume
-1.53% +0.97% -0.43% +1.26% -1.05% Change
More quotes
Financials (EUR)
Sales 2019 428 M
EBIT 2019 62,5 M
Net income 2019 41,9 M
Finance 2019 62,0 M
Yield 2019 -
Sales 2020 481 M
EBIT 2020 75,7 M
Net income 2020 58,3 M
Finance 2020 51,2 M
Yield 2020 -
P/E ratio 2019 71,6x
P/E ratio 2020 53,5x
EV / Sales2019 7,12x
EV / Sales2020 6,35x
Capitalization 3 105 M
More Financials
Company
Evotec specializes in research and development services for the pharmaceutical and biotechnological industries. The group's activity is organized around 3 areas: - development of broadband screening systems; - research and development of pharmaceutical products: for the neurologic, oncologic,... 
Sector
Biotechnology & Medical Research
Calendar
09/23 | 11:15amPresentation
More about the company
Surperformance© ratings of Evotec SE
Trading Rating : Investor Rating :
More Ratings
Latest news on EVOTEC SE
09/11EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
09/09EVOTEC : to attend upcoming investor conferences
AQ
09/06EVOTEC : To attend upcoming investor conferences
EQ
09/03EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
08/30EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
08/30EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
08/23EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
08/19EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
08/15EVOTEC : reports first half-year 2019 results and corporate updates
AQ
08/14EVOTEC : Reports first half-year 2019 results and corporate updates
EQ
More news
Analyst Recommendations on EVOTEC SE
More recommendations
Stock Trading Strategies
EVOTEC AG - 05/10
Good timing to go long again
BUY
More Stock Trading Analysis
Sector news : Biotechnology & Medical Research - NEC
10:20aBrazil Announces Criminal Charges Against 7 Vale Employees in Dam Collapse--U..
DJ
07:08aREGENERON PHARMACEUTICALS : Sanofi Get Positive CHMP Opinion for Dupixent
DJ
09/19Animal health sector aims to emulate Zoetis biotech leap
RE
09/18BIOGEN : to Study Higher Dose of Spinraza in Spinal Muscular Atrophy
DJ
09/16A Plan to Fight Hep C -- WSJ
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 28,80  €
Last Close Price 20,77  €
Spread / Highest target 58,9%
Spread / Average Target 38,7%
Spread / Lowest Target 20,4%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE20.59%3 468
IQVIA HOLDINGS INC32.50%30 152
LONZA GROUP35.89%25 876
CELLTRION, INC.--.--%18 038
INCYTE CORPORATION23.51%16 801
EXACT SCIENCES CORPORATION63.87%13 389